The Board of Directors of Nanjing Vazyme Biotech Co., Ltd. has authorized a buyback plan on August 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.37 CNY | -1.16% | -6.77% | -36.38% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.38% | 1.13B | |
+52.93% | 803B | |
+40.98% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 244B | |
+2.17% | 226B | |
+10.66% | 215B | |
+6.24% | 164B |
- Stock Market
- Equities
- 688105 Stock
- News Nanjing Vazyme Biotech Co.,Ltd
- Nanjing Vazyme Biotech Co., Ltd. authorizes a Buyback Plan.